Showing results (391-400 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|August 19, 2022
Novel Therapies in Myelofibrosis: Beyond JAK InhibitorsJulian A Waksal, John MascarenhasCurrent Hematologic Malignancy Reports|December 14, 2023
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology DisordersTerra Lasho, Mrinal M PatnaikCurrent Hematologic Malignancy Reports|November 6, 2023
Measurable Residual Disease Monitoring in LymphomaBrian Cuzzo, Andrew Lipsky, Hua-Jay J CherngCurrent Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.Current Hematologic Malignancy Reports|August 11, 2023
EBV Reactivation and Lymphomagenesis: More Questions than AnswersMaegan Ford, Evelyn Orlando, Jennifer Effie AmengualCurrent Hematologic Malignancy Reports|August 24, 2023
Central Nervous System Relapse in T and NK cell LymphomasEleanor P Taranto, Stefan K Barta, Rahul S BhansaliCurrent Hematologic Malignancy Reports|June 1, 2023
Sporadic and Familial Acute Myeloid Leukemia with CEBPA MutationsJi Yuan, Rong He, Hassan B AlkhateebCurrent Hematologic Malignancy Reports|October 3, 2023
Genetic Counseling and Family Screening Recommendations in Patients with Telomere Biology DisordersLaura Ongie, Hannah A Raj, Katie Barrett StevensCurrent Hematologic Malignancy Reports|February 23, 2026
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World ApplicationsValerie Tran, Nandan Srinivasa, Caroline Tatum, et al.Current Hematologic Malignancy Reports|April 1, 2014
FLT3 inhibitors in AML: are we there yet?Akshay Sudhindra, Catherine Choy SmithPageof 86